Social networks
381 573 42,711Entity types
Location
21 Chem. de la Sauvegarde, 69130 Écully, France
Écully
France
Employees
Scale: 1001-5000
Estimated: 1,305
SIREN
444465736Engaged catalyst
39Added in Motherbase
4 years, 1 month agoOur science for your future
SEQENS is a worldwide leader in pharmaceutical solutions and specialty ingredients.
The group generates a revenue of 1.1 MM€ and operates 16 manufacturing plants and 9 R&D centers in Europe, North America and Asia. 3,300 employees contribute to the success of SEQENS, among which 350 scientists, engineers and experts who develop tailor-made solutions for our customers.
SEQENS is an integrated player offering a broad portfolio of active ingredients, pharmaceutical intermediates and specialty ingredients. We develop and industrialize the most demanding molecules, and rely on our ability to innovate, develop and implement the best available technologies.
Pharmaceutical Synthesis, Specialty Ingredients, Cosmetics, Custom Specialties, R&D, CDMO, CRDO, Generics, Innovative Pharmaceuticals, and Personnal Care
Our science for your future
Seqens est un leader mondial de la synthèse pharmaceutique et des ingrédients de spécialité.
Le groupe génère un chiffre d'affaires de 1.1 milliard d'€ et exploite 16 sites de production ainsi que 9 centres de R&D en Europe, en Amérique du Nord et en Asie. 3 300 collaborateurs contribuent au succès de Seqens, parmi lesquels plus de 350 scientifiques, ingénieurs et experts qui développent des solutions sur mesure pour nos clients.
Seqens est un acteur intégré qui offre un large portefeuille de principes actifs, d'intermédiaires pharmaceutiques et d'ingrédients de spécialité. Nous développons et industrialisons les molécules les plus exigeantes, en prenant appui sur notre capacité à innover, à développer et à mettre en œuvre les meilleures technologies disponibles.
SEQENS is an integrated global leader in Health, Personal Care and Specialty Ingredients with 16 production sites and 9 R&D centres across the world,
Catalyst | Type | Tweets | Articles | |
---|---|---|---|---|
![]() Axel'One Research Services | Axel'One Research Services | Other 20 Sep 2023 | | |
![]() Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Medicen Paris Region Public business cluster, French Cluster, Civic and Social Organizations | Other 21 Jun 2024 | | |
![]() Novartis Pharmaceutical, Pharmaceutical Manufacturing | Novartis Pharmaceutical, Pharmaceutical Manufacturing | Other 27 Nov 2023 | | |
![]() Huawei Electricals, Telecommunications | Huawei Electricals, Telecommunications | Other 12 Jul 2023 | | |
![]() Accenture Consulting, audit, Business Consulting and Services | Accenture Consulting, audit, Business Consulting and Services | Other 12 Jul 2023 | | |
![]() Salesforce IT services, Internet | Salesforce IT services, Internet | Other 19 Jul 2023 | | |
![]() La French Tech Media, Government Administration | La French Tech Media, Government Administration | Other 12 Jul 2023 | | |
![]() European Parliament European Union, Political Organizations | European Parliament European Union, Political Organizations | Other 13 Mar 2025 | | |
![]() UN Africa Renewal International development, International Affairs | UN Africa Renewal International development, International Affairs | Other 5 Jun 2024 | | |
![]() bioMérieux Biotechnology, Biotechnology Research | bioMérieux Biotechnology, Biotechnology Research | Other 24 Jun 2023 | |